Control of Tyrosine Kinase Signalling by Small Adaptors in Colorectal Cancer

被引:6
作者
Mevizou, Rudy [1 ]
Sirvent, Audrey [1 ]
Roche, Serge [1 ]
机构
[1] Univ Montpellier, Equipe Labellisee Ligue Canc, CNRS, CRBM, F-34000 Montpellier, France
关键词
cell signalling; tyrosine kinase; small adaptor proteins; colorectal cancer; targeted therapy; SRC FAMILY KINASES; COLON-CANCER; CELL-PROLIFERATION; C-SRC; MYELOPROLIFERATIVE NEOPLASM; ABERRANT METHYLATION; HEMATOPOIETIC STEM; NEGATIVE REGULATOR; TUMOR PROGRESSION; PROTEIN SLAP;
D O I
10.3390/cancers11050669
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tyrosine kinases (TKs) phosphorylate proteins on tyrosine residues as an intracellular signalling mechanism to coordinate intestinal epithelial cell communication and fate decision. Deregulation of their activity is ultimately connected with carcinogenesis. In colorectal cancer (CRC), it is still unclear how aberrant TK activities contribute to tumour formation because TK-encoding genes are not frequently mutated in this cancer. In vertebrates, several TKs are under the control of small adaptor proteins with potential important physiopathological roles. For instance, they can exert tumour suppressor functions in human cancer by targeting several components of the oncogenic TK signalling cascades. Here, we review how the Src-like adaptor protein (SLAP) and the suppressor of cytokine signalling (SOCS) adaptor proteins regulate the SRC and the Janus kinase (JAK) oncogenic pathways, respectively, and how their loss of function in the intestinal epithelium may influence tumour formation. We also discuss the potential therapeutic value of these adaptors in CRC.
引用
收藏
页数:20
相关论文
共 50 条
[21]   Notch3 signalling promotes tumour growth in colorectal cancer [J].
Serafin, Valentina ;
Persano, Luca ;
Moserle, Lidia ;
Esposito, Giovanni ;
Ghisi, Margherita ;
Curtarello, Matteo ;
Bonanno, Laura ;
Masiero, Massimo ;
Ribatti, Domenico ;
Stuerzl, Michael ;
Naschberger, Elisabeth ;
Croner, Roland S. ;
Jubb, Adrian M. ;
Harris, Adrian L. ;
Koeppen, Hartmut ;
Amadori, Alberto ;
Indraccolo, Stefano .
JOURNAL OF PATHOLOGY, 2011, 224 (04) :448-460
[22]   Advances of Wnt Signalling Pathway in Colorectal Cancer [J].
Zhu, Yaoyao ;
Li, Xia .
CELLS, 2023, 12 (03)
[23]   Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer [J].
Hu, Liang ;
Chen, Hai-Yang ;
Cai, Jian ;
Zhang, Yu ;
Qi, Chen-Ye ;
Gong, Hui ;
Zhai, Yan-Xia ;
Fu, Hao ;
Yang, Guang-Zhen ;
Gao, Chun-Fang .
BMC CANCER, 2015, 15
[24]   Alternative splicing of spleen tyrosine kinase differentially regulates colorectal cancer progression [J].
Ni, Beibei ;
Hu, Jun ;
Chen, Dianke ;
Li, Li ;
Chen, Daici ;
Wang, Jianping ;
Wang, Lei .
ONCOLOGY LETTERS, 2016, 12 (03) :1737-1744
[25]   Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer [J].
Liang Hu ;
Hai-Yang Chen ;
Jian Cai ;
Yu Zhang ;
Chen-Ye Qi ;
Hui Gong ;
Yan-Xia Zhai ;
Hao Fu ;
Guang-Zhen Yang ;
Chun-Fang Gao .
BMC Cancer, 15
[26]   Tyrosine kinase inhibitors with antiangiogenic properties for the treatment of non-small cell lung cancer [J].
Nguewa, Paul A. ;
Calvo, Alfonso ;
Pullamsetti, Soni Savai ;
Banat, Gamal Andre ;
Grimminger, Friedrich ;
Savai, Rajkumar .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (01) :61-74
[27]   Cell signalling: Growth factors and tyrosine kinase receptors [J].
Perona R. .
Clinical and Translational Oncology, 2006, 8 (2) :77-82
[28]   Small Molecule Tyrosine Kinase Inhibitors: The New Dawn for Cancer Therapy [J].
Noolvi, Malleshappa N. ;
Patel, Harun M. .
LETTERS IN DRUG DESIGN & DISCOVERY, 2012, 9 (01) :84-125
[29]   Small molecule inhibitors of the VEGF and tyrosine kinase for the treatment of cervical cancer [J].
Sarwar, Fatima ;
Ashhad, Samreen ;
Vimal, Archana ;
Vishvakarma, Reena .
MEDICAL ONCOLOGY, 2024, 41 (08)
[30]   Mechanisms of receptor tyrosine kinase activation in cancer [J].
Du, Zhenfang ;
Lovly, Christine M. .
MOLECULAR CANCER, 2018, 17